INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

74,196 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
RP
Rackliffe PhilipCEO, AIS
GEHCGE HealthCare Technologies Inc.
Tax withholding
F$24K
340 sh
Sep 1, 2026Sep 3, 2026
Page 482 of 1855
← PrevNext →
traded Sep 1, 2026
+2d
SEC Form 4

Evidence

9
BD
Bersaglini Clark DavidVice President
KMTKENNAMETAL INC
Option exercise
M—
11.6K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

8
MB
Mulligan BrendanGeneral Counsel and Secretary
FIGFigma, Inc.
Tax withholding
F$259K
9,435 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

8
RS
Randhawa SimratEVP, Head of R&D
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$273K
2,600 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

8
EW
Ellingson Alan WayneChief Financial Officer
DKNGDraftKings Inc.
Tax withholding
F$60K
2,563 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

8
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Derivative conversion
C$649K
24.2K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

8
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Derivative conversion
C$406K
4,999 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

8
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
858 sh
Sep 3, 2026Sep 3, 2026
traded Sep 3, 2026
+0dSEC Form 4

Evidence

7
LY
Le Pendeven YvesCFO
FNKOFunko, Inc.
Open-market sale · 10b5-1 plan
SELL$12K
1,833 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

7
RS
Randhawa SimratEVP, Head of R&D
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M$134K
7,500 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

7
RS
Randhawa SimratEVP, Head of R&D
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M$207K
9,375 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

7
SP
Smith Kevin P.EVP, Bus Dev, GC & Sec
INGNInogen Inc
Tax withholding · 10b5-1 plan
F$46K
8,671 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

7
CE
Colburn Richard Edward IIIChief Product & Tech Officer
ETSYETSY INC
Open-market sale · 10b5-1 plan
SELL$40K
479 sh
Sep 3, 2026Sep 3, 2026
traded Sep 3, 2026
+0dSEC Form 4

Evidence

7
RM
Rodrigues Fernando M.President of BetterHelp
TDOCTeladoc Health, Inc.
Option exercise · 10b5-1 plan
M—
8,717 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

7
RS
Randhawa SimratEVP, Head of R&D
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M$136K
6,249 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

7
VN
Viljoen NataschaDirector, President & CEO
NEMNEWMONT Corp /DE/
Open-market sale · 10b5-1 plan
SELL$477K
3,882 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

7
GK
Guarini KathrynDirector
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M—
400 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

7
RM
Rodrigues Fernando M.President of BetterHelp
TDOCTeladoc Health, Inc.
Option exercise · 10b5-1 plan
M—
1,042 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

6
VS
Verma ShivChief Financial Officer
HOODRobinhood Markets, Inc.
Option exercise
M—
9,692 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

6
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$193K
600 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

6
YT
Yoon William TChief Legal Officer
DBXDROPBOX, INC.
Grant or award
A—
28.9K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

6
TP
Tuffin PaulaGeneral Counsel and CCO
BETRBetter Home & Finance Holding Co
Grant or award
A—
6,132 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

6
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$59K
1,368 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

6
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Option exercise
M—
408 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

6
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Tax withholding
F$13K
206 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

6
VS
Verma ShivChief Financial Officer
HOODRobinhood Markets, Inc.
Option exercise
M—
23.6K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

5
OG
O'Brien Michael GrahamCFO
GTMZoomInfo Technologies Inc.
Tax withholding
F$1,136
268 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

5
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Derivative conversion
C$245K
3,067 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

5
EW
Ellingson Alan WayneChief Financial Officer
DKNGDraftKings Inc.
Tax withholding
F$24K
1,035 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

5
OG
O'Brien Michael GrahamCFO
GTMZoomInfo Technologies Inc.
Option exercise
M—
328 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

5
EW
Ellingson Alan WayneChief Financial Officer
DKNGDraftKings Inc.
Option exercise
M—
742 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

5
BC
Barrett CherieSVP, Chief Accounting Officer
DOCNDigitalOcean Holdings, Inc.
Tax withholding · 10b5-1 plan
F$343K
3,103 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

5
BJ
Barry JamesEVP, President, LSG
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
251 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

5
BJ
Barry JamesEVP, President, LSG
BIOBIO.BBIO-RAD LABORATORIES, INC.
Option exercise
M—
174 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

5
OG
O'Brien Michael GrahamCFO
GTMZoomInfo Technologies Inc.
Option exercise
M—
328 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

5
TM
Taylor Daniel MarkPresident FLUT; CEO FLUT Intl
FLUTFlutter Entertainment plc
Disposition to issuer
D—
7,902 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

5
EW
Ellingson Alan WayneChief Financial Officer
DKNGDraftKings Inc.
Option exercise
M—
2,140 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

5
BK
Bliss KellyPresident, U.S. Group Health
TDOCTeladoc Health, Inc.
Option exercise
M—
1,300 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

5
TM
Taylor Daniel MarkPresident FLUT; CEO FLUT Intl
FLUTFlutter Entertainment plc
Grant or award
A—
13.5K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

5
OG
O'Brien Michael GrahamCFO
GTMZoomInfo Technologies Inc.
Option exercise
M—
214 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence